title: Long-term treatment with standardized extract of Ginkgo biloba L. enhances the conditioned suppression of licking in rats by the modulation of neuronal and glial cell function in the dorsal hippocampus and central amygdala.
abstract: Our group previously demonstrated that short-term treatment with a standardized extract of Ginkgo biloba (EGb) changed fear-conditioned memory by modulating gene expression in the hippocampus, amygdaloid complex and prefrontal cortex. Although there are few controlled studies that support the long-term use of EGb for the prevention and/or treatment of memory impairment, the chronic use of Ginkgo is common. This study evaluated the effects of chronic treatment with EGb on the conditioned emotional response, assessed by the suppression of ongoing behavior and in the modulation of gene and protein expression. Male adult Wistar rats were treated over 28days and assigned to five groups (n=10) as follows: positive control (4mgkg(-1) Diazepam), negative control (12% Tween 80), EGb groups (0.5 and 1.0gkg(-1)) and the naïve group. The suppression of the licking response was calculated for each rat in six trials. Our results provide further evidence for the efficacy of EGb on memory. For the first time, we show that long-term treatment with the highest dose of EGb improves the fear memory and suggests that increased cAMP-responsive element-binding protein (CREB)-1 and glial fibrillary acidic protein (GFAP) mRNA and protein (P<0.001) in the dorsal hippocampus and amygdaloid complex and reduced growth and plasticity-associated protein 43 (GAP-43) (P<0.01) in the hippocampus are involved in this process. The fear memory/treatment-dependent changes observed in our study suggest that EGb might be effective for memory enhancement through its effect on the dorsal hippocampus and amygdaloid complex.
authors: Behavior Pharmacology and Etnopharmacology Laboratory, Department of Biological Science, Universidade Federal de Sao Paulo, SP, Brazil.
authors: D R
authors: DR
authors: Oliveira
authors: P F
authors: PF
authors: Sanada
authors: A C S
authors: AC
authors: Filho
authors: G M S
authors: GM
authors: Conceição
authors: J M
authors: JM
authors: Cerutti
authors: S M
authors: SM
authors: Cerutti
mesh_terms: D000679:Amygdala / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D003216:Conditioning, Operant / Q000187:drug effects*; D017362:Cyclic AMP Response Element-Binding Protein / Q000096:biosynthesis; D003627:Data Interpretation, Statistical; D003975:Diazepam / Q000494:pharmacology; D005239:Fear / Q000187:drug effects; D019922:GAP-43 Protein / Q000096:biosynthesis; D020441:Ginkgo biloba / Q000737:chemistry*; D005904:Glial Fibrillary Acidic Protein / Q000096:biosynthesis / Q000235:genetics; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007150:Immunohistochemistry; D008297:Male; D008568:Memory / Q000187:drug effects; D009457:Neuroglia / Q000187:drug effects*; D009473:Neuronal Plasticity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects*; D010936:Plant Extracts / Q000494:pharmacology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D017362:Cyclic AMP Response Element-Binding Protein; D019922:GAP-43 Protein; D005904:Glial Fibrillary Acidic Protein; D006993:Hypnotics and Sedatives; D010936:Plant Extracts; D003975:Diazepam